The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $2.03 in the prior trading day, Heron Therapeutics Inc (NASDAQ: HRTX) closed at $1.95, down -3.94%. In other words, the price has decreased by -$3.94 from its previous closing price. On the day, 3.22 million shares were traded.
Ratios:
Our goal is to gain a better understanding of HRTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.76 and its Current Ratio is at 2.40.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 09, 2025, initiated with a Buy rating and assigned the stock a target price of $6.
On June 13, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $7.
On April 23, 2024, CapitalOne started tracking the stock assigning a Overweight rating and target price of $6.CapitalOne initiated its Overweight rating on April 23, 2024, with a $6 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.00.
Stock Price History:
Over the past 52 weeks, HRTX has reached a high of $3.73, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is -3.70%, while the 200-Day Moving Average is calculated to be 4.91%.
Shares Statistics:
A total of 152.43M shares are outstanding, with a floating share count of 151.13M. Insiders hold about 0.94% of the company’s shares, while institutions hold 82.00% stake in the company.
